Clinical Trial Update: Evaluating Aranesp® for the Treatment of Anemia in African-American Subjects With Chronic Renal Failure (CRF) Receiving Hemodialysis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial completed evaluating Aranesp (darbepoetin alfa) for treatment of anemia in African-American patients with chronic kidney disease on hemod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• ARANESP (DARBEPOETIN ALFA)

Snippet

Sponsor: Amgen | Conditions: Chronic Renal Failure, Anemia | Phase 4 | Status: COMPLETED